| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACTG1
|
actin gamma 1
|
|
BID
|
BH3 interacting domain death agonist
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV3
|
caveolin 3
|
|
CCND1
|
cyclin D1
|
|
CD28
|
CD28 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CYCS
|
cytochrome c, somatic
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DMD
|
dystrophin
|
|
DTNA
|
dystrobrevin, alpha
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2
|
|
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DOA
|
major histocompatibility complex, class II, DO alpha
|
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMA2
|
laminin, alpha 2
|
|
LOC102724971
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha
|
|
MYH7
|
myosin, heavy chain 7, cardiac muscle, beta
|
|
NANOS1
|
nanos homolog 1 (Drosophila)
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
POTEF
|
POTE ankyrin domain family, member F
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
|
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)
|
|
SGCB
|
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
|
|
SGCD
|
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SGCZ
|
sarcoglycan, zeta
|
|
SNTA1
|
syntrophin, alpha 1
|
|
SNTB1
|
syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1)
|
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)
|
|
SSPN
|
sarcospan
|
|
ZNF395
|
zinc finger protein 395
|
